Cancer cells can evade antitumor immunity through packaging immunosuppressive mediators, such as FasL, TNF-associated apoptosis inducing ligand (TRAIL), transforming growth factor-β (TGF-β), and PD-L1 into their exosomes and affect T-CD8 + cell activity [64]. This evidence concerns the gene CD8A and cancer.